Evaluation of the Effect of Sitagliptin on Gut Microbiota in Patients With Newly Diagnosed Type 2 Diabetes

• Status: Unknown status
• Trial end date: 2016-11-01
• Target enrollment: 0
• Participant gender: All

Summary

The present study will recruit 9 newly diagnosed type 2 diabetic patient to receive sitagliptin 100mg daily for 12 weeks. The aim of this study was to investigate the composition of gut microbiota before and after the therapy of sitagliptin.

• Phase: N/A
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Second Affiliated Hospital of Soochow University
• Treatments: Sitagliptin Phosphate

Criteria

Inclusion Criteria:

• Newly-diagnosed type 2 diabetic patients aged between 40-70 years

Exclusion Criteria:

• Any chronic disease (other than diabetes)

• Alcohol consumption/smoking

• Pregnancy/breastfeeding

• The use of antibiotics, pro-prebiotics within 3 months

• History of intestinal surgery